drugset / Trial / NCT01687491
Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome
Phase 4
Completed
179 enrolled
Les Laboratoires des Médicaments Stériles
University Hospital Fattouma Bourguiba · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is a clinical trial monocentric, open, randomized ENOXA ® versus LOVENOX ®, conducted on two parallel groups of patients admitted in emergency for acute coronary syndrome.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-05
- Completion
- 2014-10
Publications
- Background Boubaker H MD, Grissa MH MD, Sassi M MD, Chakroun T MD, Beltaief K MD, et al. (2015) Generic and Branded Enoxaparin Bioequivalence: A Clinical and Experimental Study. J Bioequiv Availab 7: 225-228. doi:10.4172/jbb.1000244
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | 100 iu/kg | Subcutaneous |